HPV vaccine before pregnancy lowers preterm birth risk study finds

Receiving a human papillomavirus vaccine prior to pregnancy is linked to a reduced risk of major pregnancy complications, including preterm birth. PULSE Today reported on October 12, 2026, that a Swedish analysis published in the BMJ demonstrated additional health benefits of the vaccine beyond cancer prevention. [1]

Researchers discovered that the protective effect was most pronounced among individuals who received the vaccine at a younger age. According to PULSE Today, the findings highlight advantages that extend directly to maternal and child health outcomes. [1]

As FTMQ Health reported earlier, other maternal factors also influence pregnancy duration. Research into omega three supplementation indicates that specific genetic variants affect how docosahexaenoic acid doses impact the timing of childbirth, particularly regarding spontaneous early preterm birth occurring before 34 weeks of gestation. [2]